What question did this study set out to answer?

This research aims to compare the continuous glucose monitoring profiles of different glucose-lowering medications in diabetes management.

April 4, 2026

Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial

Key Points

This research aims to compare the continuous glucose monitoring profiles of different glucose-lowering medications in diabetes management.
Analyzed CGM metrics across four glucose-lowering medications
Evaluated %CV (coefficient of variation) for each medication
Assessed achievement of CGM-based glycemic targets
Incretin drugs exhibited the lowest %CV among the medications
Incretin usage resulted in the least occurrences of hypoglycemia
Best achievement of CGM-based glycemic targets was noted with incretin class drugs

Abstract

Incretin class drugs had the lowest %CV, the least hypoglycemia, and best achievement of CGM-based glycemic targets. CGM metrics and profiles provide clinical insights, beyond HbA1c, to guide diabetes management.

Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial

Key Points

Abstract

Cite This Study

Also Consider

Also Consider